Mangalam Cements: All eyes on board meeting of 22nd Nov.
Supen Diagnostic: Bags huge order of Rs. 9.24 crores from UN.
J.P. Associates: Buy at every dip in the price.
GMR Infra: Huge movement expected on the counter.
KRBL: Well-known broking firm has interest on the counter.
Deccan Chronicles: target price of Rs. 60.
Renuka Sugars: Net profit doubled during quarter ended in September.
Mastek: Sound investment for long term.
Union Bank: Plans to open 500 new branches in next five months.
RIL likely to bottom out: Emami: expected to reap benefit of expansion.
TCS: Attractive investment for investors with risk appetite.
IVRCL Infra: Speedy recovery expected.
ICICI Bank: best buy for short term.
HPCL: expected to reap benefit of reducing crude price.
BOI: safe bet at current price.
IPCA Labs: counter is expected to see current on buyback offer.
Maharashtra seamless: Investors fancy is rising due to huge order from ONGC.
Tata power: No possibility of reduction in price.
Hindustan Zinc: Possibilities of more correction as profit booking is on.
FMCG & Pharma seems to be safe bet at this time.
GMR has deferred Mangalore power plant.
SKF has shelve its Rs. 150 Cr. : Plant at hardware.
Torrent Power will start trial production in Sujan Plant.
J B Chemicals has planned 150 cr. investments in pharma SEZ.
RIL has picked 67 % stake in AP Pipeline Co.
BHEL is planning to tie-up with L & T for new nuclear orders.
Tata Tea : It is trading at an attractive forward PE of 8.
BHEL : Major beneficiary from nuclear deal.
Satyam : Worth investment for medium to long term.
Sterlite Ind. : Dark horse for long term Investment.
M & M : Buy this share & Enjoy long drive.